Ksenia
Фея
В этой статье предложили сделать то, что я предлагал еще 3 года назад. Загрузка статьи
We argue that current medical treatments (i.e., anti-Parkinson drugs) that manipulate the levels of those Curr Sex Health Rep neurotransmitters (i.e., dopamine), or perhaps new treatments that require enhancement of brain oxytocin, may result in the possible modification of sexual preferences, especially if contingency and contiguity facilitate the association of the reinforcer and a new partner. For instance, one
ular case in the media reported a man who changed his heterosexual preference for homosexual as a result of long-term treatment with the anti-Pakinson drug ropinirole (D2-type agonist) [88••]. Cases like this indicate that further research is needed to shed light on the nature of sexual preferences and the potential side effects of current medicine. In addition, the powerful effects of conditioning under enhanced D2 or oxytocin activity indicate new potential direction for the therapy of chronophilias or paraphilias
We argue that current medical treatments (i.e., anti-Parkinson drugs) that manipulate the levels of those Curr Sex Health Rep neurotransmitters (i.e., dopamine), or perhaps new treatments that require enhancement of brain oxytocin, may result in the possible modification of sexual preferences, especially if contingency and contiguity facilitate the association of the reinforcer and a new partner. For instance, one
ular case in the media reported a man who changed his heterosexual preference for homosexual as a result of long-term treatment with the anti-Pakinson drug ropinirole (D2-type agonist) [88••]. Cases like this indicate that further research is needed to shed light on the nature of sexual preferences and the potential side effects of current medicine. In addition, the powerful effects of conditioning under enhanced D2 or oxytocin activity indicate new potential direction for the therapy of chronophilias or paraphilias
